Final hours! Save up to 55% OFF InvestingProCLAIM SALE

Anthem must face U.S. government lawsuit alleging Medicare Advantage fraud

Published 10/03/2022, 01:34 PM
Updated 10/03/2022, 01:43 PM
© Reuters.
CRI
-

By Jonathan Stempel

NEW YORK (Reuters) - A federal judge ordered Anthem Inc to face a U.S. government lawsuit claiming it submitted inaccurate diagnosis data, enabling the health insurer to fraudulently collect tens of millions of dollars in annual overpayments from Medicare.

In a decision released on Monday, U.S. District Judge Andrew Carter in Manhattan said the total alleged overpayment to Anthem appeared to be well over $100 million, making the government's financial costs "substantial and not merely administrative."

A lawyer for Anthem declined to comment. The Indianapolis-based insurer did not immediately respond to a request for comment.

The Department of Justice lawsuit filed in March 2020 stemmed from Anthem's operation of dozens of Medicare Part C plans, also known as Medicare Advantage, a privatized system that insures Americans who opt out of traditional Medicare.

Anthem was accused of not checking the accuracy of diagnosis codes it submitted when seeking reimbursements between early 2014 and early 2018, because deleting invalid codes would have reduced revenue.

One company executive was quoted in 2016 as saying Anthem viewed its "retrospective chart review," which supplemented codes it had already collected from doctors, as a "cash cow."

The Justice Department sued Anthem under the federal False Claims Act, which prohibits submitting false payment claims, and sought civil fines and triple damages. Carter's (NYSE:CRI) decision is dated Sept. 30.

Anthem's case is one of multiple Justice Department civil lawsuits against companies that participate in Medicare Advantage.

The government watchdog MedPac said excess Medicare Advantage billing linked to what it calls "coding intensity" reached $12 billion in 2020.

© Reuters. The logo for health insurance provider, Anthem, is displayed on a screen on the floor at the New York Stock Exchange (NYSE) in New York, U.S., April 9, 2019. REUTERS/Brendan McDermid

Enrollment in Medicare Advantage has doubled since 2013 to about 28.7 million, or approximately 49% of all eligible Medicare beneficiaries, MedPac said in July.

The case is U.S. v. Anthem Inc, U.S. District Court, Southern District of New York, No. 20-02593.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.